Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical chemotherapeutics among cancer survivors. Despite the recent progress, the effective prevention and treatment strategies for CIPN remain limited. Better understanding of the pathogenesis of CIPN may provide new nich...

Full description

Bibliographic Details
Main Authors: Chih-Hung Tsai, Yuan-Ho Lin, Yung-Sheng Li, Trung-Loc Ho, Le Huynh Hoai Thuong, Yu-Huei Liu
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
chemotherapy-induced peripheral neuropathy
cancer survivors
new drug development
alternative and complimentary medicines
Online Access:https://www.mdpi.com/1422-0067/22/17/9257
Description
Summary:Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical chemotherapeutics among cancer survivors. Despite the recent progress, the effective prevention and treatment strategies for CIPN remain limited. Better understanding of the pathogenesis of CIPN may provide new niches for developing a new ideal therapeutic strategy. This review summarizes the current understanding of CIPN and current recommendations along with completed/active clinical trials and aims to foster translational research to improve the development of effective strategies for managing CIPN.
ISSN:1661-6596
1422-0067

Similar Items